Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 1.17
-10.7 %
$ 15.6 M
Market Cap
-1.3
P/E
CASH FLOW STATEMENT
-8.4 M
OPERATING CASH FLOW
-234 K
INVESTING CASH FLOW
3.15 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Flora Growth Corp.
| Net Income | -47.4 M |
| Depreciation & Amortization | 2.48 M |
| Capital Expenditures | -163 K |
| Stock-Based Compensation | 1.59 M |
| Change in Working Capital | -661 K |
| Others | 34.4 M |
| Free Cash Flow | -8.56 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (47.4) | (52.6) | (21.4) | (14.3) | (2.8) |
| Depreciation & Amortization | 2.5 | 2.6 | 0.8 | 0.1 | 25.9 K |
| Deferred Income Tax | (1.6) | (1.5) | 98 K | 1.8 | (1.9) |
| Stock Based Compensation | 1.6 | 3.4 | 1.3 | 4.9 | 1.8 |
| Other Operating Activities | 37.2 | 28.4 | 3.7 | 30 K | 1.6 |
| Change in Working Capital | (0.7) | 3.8 | (5.0) | (0.9) | 0.8 |
| Cash From Operations | (8.4) | (15.9) | (20.6) | (8.4) | (0.5) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (0.2) | (1.3) | (4.0) | (0.2) | (0.1) |
| Other Items | 71 K | (14.5) | (10.6) | (1.9) | (0.3) |
| Cash From Investing Activities | (0.2) | (15.8) | (14.6) | (2.2) | (0.4) |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | (0.3) | 0 | 0 | 0 |
| Total Debt Repaid | 0.8 | 1 K | (0.3) | 64 K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.4) | (0.3) | 15.8 | (4.1) | 1.0 |
| Cash From Financing Activities | 3.1 | 4.4 | 58.1 | 25.8 | 1.0 |
| CHANGE IN CASH | |||||
| Net Change In Cash | (4.5) | (28.1) | 22.1 | 15.4 | 0.1 |
| FREE CASH FLOW | |||||
| Free Cash Flow | (8.6) | (17.2) | (24.6) | (8.7) | (0.6) |